로딩 중…
지수 로딩 중…
Twist Bioscience Corporation
TWST· NASDAQ· Health Care· Health Care Equipment & Services
$166.99+7.35%
2026-09-18
Financials
Valuation Metrics
Twist Bioscience Corporation's Market Cap is $10.40B. At end of 2025 it was $1.94B. Ranked #944 of 3,121 in US market (top 30%), #305 of 1,463 on NASDAQ (top 21%), #68 of 205 in Health Care Equipment & Services (top 33%) by Market Cap.
Investment Metrics(as of 2026-09-18)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | $10.40B | US#944/3,121 Sec#68/205 |
| Revenue | $432M | US#2,329/3,121 Sec#145/205 |
| Net Income | $-137M | US—/3,121 Sec—/205 |
| Total Assets | $672M | US#2,652/3,121 Sec#147/205 |
| Net Assets | $446M | US#2,308/3,121 Sec#120/205 |
| Value | ||
| P/B | 23.33x | US#2,808/3,121 Sec#181/205 |
| P/S | 24.08x | US#2,860/3,121 Sec#200/205 |
| FCF Yield | -0.90% | US—/3,121 Sec—/205 |
| Profitability | ||
| ROE | -30.67% | US#2,571/3,121 Sec#157/205 |
| ROA | -20.33% | US#2,800/3,121 Sec#178/205 |
| Op. Margin | -31.91% | US#2,645/3,121 Sec#171/205 |
| Revenue Growth | 19.19% | US#725/3,121 Sec#47/205 |
| Financial Health | ||
| Debt Ratio | 50.86% | US#581/3,121 Sec#64/205 |
| Total Debt | $94M | US#2,458/3,121 Sec#139/205 |
| FCF | $-93M | US#2,618/3,121 Sec#188/205 |
| Cash | $117M | US#2,117/3,121 Sec#129/205 |
| Current Ratio | 2.67x | US#906/3,121 Sec#91/205 |
| Performance | ||
| 1Y Return | 497.46% | US#13/3,121 Sec#2/205 |
| 1M Return | 17.28% | US#32/3,121 Sec#7/205 |
| From 52W High | -0.02% | US#311/3,121 Sec#37/205 |
| 1Y MDD | -25.54% | US#1,088/3,121 Sec#33/205 |
| Trading | ||
| Volume | 2,896,401 shares | US#518/3,121 Sec#25/205 |
| Trading Value | $473M | US#174/3,121 Sec#10/205 |
| Per Share | ||
| EPS | $-2.20 | US—/3,121 Sec—/205 |
| BPS | $7.16 | US#2,075/3,121 Sec#122/205 |